Profilaxis de enfermedad de Chagas en niños y adultos sometidos a trasplante de órganos sólidos y de precursores hematopoyéticos / Prophylaxis against Chagas disease in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation
Rev. chil. infectol
; 29(supl.1): 41-44, set. 2012. tab
Article
in Spanish
| LILACS
| ID: lil-656326
Responsible library:
CL1.1
ABSTRACT
Chagas disease is a zoonosis caused by T. cruzi. The estimated prevalence in endemic areas is 0.6-0.9 / 100,000. In immunocompromised behaves as an opportunistic pathogen highly aggressive and can evolve with meningoencephalitis, myocarditis or systemic disease. We recommend obtaining serology for all donor and recipient of SOT and HSCT. An infected donor should be discarded as such. In the case of D (-) R (+) exists controversy between prophylaxis and pre emptive therapy. The chosen drug for prophylaxis is nifurtimox for 3 months, effective but with relevant adverse effects. Monitoring should be done with RPC and MicroStrout weekly until six months post-transplant, then on a monthly basis for the duration of immunosuppression and continued for life clinical monitoring (C3).
RESUMEN
La enfermedad de Chagas es una zoonosis producida por T. cruzi. La prevalencia estimada en áreas endémicas es de 0,6-0,9/100.000 habitantes . En inmunocomprome-tidos se comporta como un patógeno oportunista de alta agresividad, pudiendo evolucionar con cuadros meningo-encefálicos, miocárdicos o sistémicos. Se recomienda obtener serología para todo donante y receptor de TOS y TPH. Un donante infectado se descarta como tal. En caso de D (-) R (+) existe controversia entre realizar proilaxis o vigilancia más terapia anticipada. La proilaxis aceptada es con nifurtimox por tres meses, efectiva pero con efectos adversos importantes. El seguimiento debe realizarse con RPC y MicroStrout semanal hasta los seis meses post-trasplante; luego, en forma mensual mientras dure la inmunosupresión y continuar de por vida la vigilancia clínica (C3).
Full text:
Available
Collection:
International databases
Health context:
SDG3 - Health and Well-Being
/
Neglected Diseases
/
SDG3 - Target 3.3 End transmission of communicable diseases
Health problem:
Target 3.3: End transmission of communicable diseases
/
Chagas Disease
/
Neglected Diseases
/
Zoonoses
/
Meningitis
Database:
LILACS
Main subject:
Trypanocidal Agents
/
Organ Transplantation
/
Chagas Disease
/
Stem Cell Transplantation
/
Nifurtimox
Type of study:
Practice guideline
/
Observational study
/
Prognostic study
/
Risk factors
Limits:
Adult
/
Child
/
Humans
Language:
Spanish
Journal:
Rev. chil. infectol
Journal subject:
Communicable Diseases
Year:
2012
Document type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital DIPRECA/CL
/
Hospital Dr. Luis Calvo Mackenna/CL
/
Universidad de Chile/CL